Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1056)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
412
Price
$519.19
Total Value
$213.91K
Shares Held After
326,203
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,346
Price
$518.14
Total Value
$697.42K
Shares Held After
326,615
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,486
Price
$517.11
Total Value
$768.42K
Shares Held After
327,961
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,386
Price
$516.16
Total Value
$1.23M
Shares Held After
329,447
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,630
Price
$515.46
Total Value
$840.20K
Shares Held After
331,833
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$514.26
Total Value
$246.84K
Shares Held After
333,463
% of Holdings
0.1%
Immunovant, Inc. (IMVT)
Pande Atul — Director
Shares
1,500
Price
$43.27
Total Value
$64.91K
Shares Held After
116,731
% of Holdings
1.3%
BIOVIE INC. (BIVI)
Chappell Amy Suzon — Director
Shares
727
Price
$2.16
Total Value
$1.57K
Shares Held After
727
% of Holdings
100.0%
BIOVIE INC. (BIVI)
KIM JOANNE WENDY — Chief Financial Officer
Shares
2,500
Price
$2.18
Total Value
$5.45K
Shares Held After
3,441
% of Holdings
72.7%
BIOVIE INC. (BIVI)
Palumbo Joseph M — Chief Medical Officer
Shares
4,843
Price
$2.16
Total Value
$10.46K
Shares Held After
6,036
% of Holdings
80.2%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
128
Price
$61.77
Total Value
$7.91K
Shares Held After
59,745
% of Holdings
0.2%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
13,485
Price
$60.21
Total Value
$811.93K
Shares Held After
59,873
% of Holdings
18.4%
Eton Pharmaceuticals, Inc. (ETON)
MAIER PAUL V — Director
Shares
36,387
Price
$58.64
Total Value
$2.13M
Shares Held After
73,358
% of Holdings
33.2%
Emmaus Life Sciences, Inc. (EMMA)
LEE WILLIS C — Director
Shares
50,000
Price
$0.05
Total Value
$2.50K
Shares Held After
495,400
% of Holdings
10.1%
MAIA Biotechnology, Inc. (MAIA)
Guerrero Ramiro — Director
Shares
78,239
Price
$1.39
Total Value
$108.75K
Shares Held After
689,081
% of Holdings
11.4%
Chemomab Therapeutics Ltd. (CMMB)
Cohen Neil Harris — Director
Shares
1,304
Price
$2.85
Total Value
$3.72K
Shares Held After
34,000
% of Holdings
3.7%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
8,222
Price
$12.01
Total Value
$98.74K
Shares Held After
142,047
% of Holdings
5.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
300
Price
$252.76
Total Value
$75.83K
Shares Held After
65,686
% of Holdings
0.5%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
9,259
Price
$251.95
Total Value
$2.33M
Shares Held After
65,986
% of Holdings
12.3%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
19,639
Price
$250.60
Total Value
$4.92M
Shares Held After
75,245
% of Holdings
20.7%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
18,113
Price
$250.02
Total Value
$4.53M
Shares Held After
94,884
% of Holdings
16.0%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
11,423
Price
$248.67
Total Value
$2.84M
Shares Held After
112,997
% of Holdings
9.2%
Jazz Pharmaceuticals plc (JAZZ)
Iannone Robert — EVP, Global Head of R&D&CMO
Shares
18,187
Price
$247.86
Total Value
$4.51M
Shares Held After
124,420
% of Holdings
12.8%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
38,922
Price
$7.20
Total Value
$280.24K
Shares Held After
4,279,426
% of Holdings
0.9%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
38,922
Price
$7.20
Total Value
$280.24K
Shares Held After
4,279,426
% of Holdings
0.9%
Camp4 Therapeutics Corp (CAMP)
Schwab Andrew J. — Director
Shares
400,000
Price
$4.04
Total Value
$1.62M
Shares Held After
2,033,270
% of Holdings
16.4%
Cogent Biosciences, Inc. (COGT)
Morris Arlene — Director
Shares
3,161
Price
$37.54
Total Value
$118.66K
Shares Held After
0
% of Holdings
100.0%
Cogent Biosciences, Inc. (COGT)
Morris Arlene — Director
Shares
42,349
Price
$37.09
Total Value
$1.57M
Shares Held After
3,161
% of Holdings
93.1%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
2,000
Price
$13.79
Total Value
$27.58K
Shares Held After
11,005
% of Holdings
18.2%
BIOVIE INC. (BIVI)
DO CUONG V — Director
Shares
15,210
Price
$2.08
Total Value
$31.64K
Shares Held After
16,117
% of Holdings
94.4%
Arcutis Biotherapeutics, Inc. (ARQT)
Curran Terrie — Director
Shares
27,052
Price
$25.03
Total Value
$677.10K
Shares Held After
23,526
% of Holdings
53.5%
Arcutis Biotherapeutics, Inc. (ARQT)
Curran Terrie — Director
Shares
11,148
Price
$25.03
Total Value
$279.03K
Shares Held After
23,526
% of Holdings
32.2%
FENNEC PHARMACEUTICALS INC. (FENC)
Andrade Robert — CHIEF FINANCIAL OFFICER
Shares
75,000
Price
$11.78
Total Value
$883.50K
Shares Held After
217,675
% of Holdings
25.6%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
610
Price
$72.22
Total Value
$44.05K
Shares Held After
1,336,594
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
11,890
Price
$71.55
Total Value
$850.73K
Shares Held After
1,337,204
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$531.12
Total Value
$63.73K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
755
Price
$530.08
Total Value
$400.21K
Shares Held After
324,563
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,308
Price
$529.15
Total Value
$692.13K
Shares Held After
325,318
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,237
Price
$528.29
Total Value
$653.50K
Shares Held After
326,626
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$526.37
Total Value
$147.38K
Shares Held After
327,863
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
376
Price
$525.62
Total Value
$197.63K
Shares Held After
328,143
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
744
Price
$524.61
Total Value
$390.31K
Shares Held After
328,519
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$523.60
Total Value
$125.66K
Shares Held After
329,263
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$522.40
Total Value
$146.27K
Shares Held After
329,503
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
477
Price
$521.24
Total Value
$248.63K
Shares Held After
329,783
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,003
Price
$520.23
Total Value
$521.79K
Shares Held After
330,260
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$518.89
Total Value
$103.78K
Shares Held After
331,263
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$517.07
Total Value
$144.78K
Shares Held After
331,463
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$515.33
Total Value
$123.68K
Shares Held After
331,743
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$514.32
Total Value
$61.72K
Shares Held After
331,983
% of Holdings
0.0%
Showing 51–100 of 1056 transactions (page 2 of 22)